Related references
Note: Only part of the references are listed.Recomendações para o diagnóstico e tratamento das tuberculoses latente e activa nas doenças inflamatórias articulares candidatas a terapêutica com fármacos inibidores do factor de necrose tumoral alfa. Revisão de Março de 2008**O presente artigo foi publicado simultaneamente in Acta Reumatol Port 2008;33:77-85 This article has been copublished in Acta Reumatol Port 2008; 33: 77-85
João Eurico Fonseca et al.
Revista Portuguesa de Pneumologia (2015)
Psoriasis
Gayathri K. Perera et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study
S. Garcovich et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Evaluation of an IFN-gamma Assay in the Diagnosis of Latent Tuberculosis in Patients with Psoriasis in a Highly Endemic Setting
Emerson de Andrade Lima et al.
ACTA DERMATO-VENEREOLOGICA (2011)
Patients with Psoriasis are More Likely to be Treated for Latent Tuberculosis Infection Prior to Biologics than Patients with Inflammatory Bowel Disease
Ioannis D. Bassukas et al.
ACTA DERMATO-VENEREOLOGICA (2011)
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
D. Salmon-Ceron et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Innate immunity in the pathogenesis of psoriasis
Cheryl M. Sweeney et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2011)
Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-alpha treatment: every new solution breeds new doubts
A. I. Sanchez-Moya et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Clinical experience of QuantiFERON®-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan
H-Y. Chiu et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Psoriasis and melanocytic naevi: does the first confer a protective role against melanocyte progression to naevi?
N. Balato et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Clinical applicability of T-cell interferon-alpha release assay for tumour necrosis factor-alpha inhibitor therapy in severe psoriasis
Y. Z. Chiang et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2011)
What's new in psoriasis? An analysis of guidelines and systematic reviews published in 2009-2010
A. C. Foulkes et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2011)
Clinical utility of QuantiFERON-TB GOLD In-Tube and tuberculin skin test in patients with tuberculous pleural effusions
Jae Ho Chung et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study
Bu B. Yeap et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
INSULIN-LIKE GROWTH FACTOR-1, PSORIASIS, AND INFLAMMATION: A MENAGE A TROIS?
S. Savastano et al.
EUROPEAN JOURNAL OF INFLAMMATION (2011)
The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity
Wolf-Henning Boehncke et al.
EXPERIMENTAL DERMATOLOGY (2011)
Tuberculin skin test and QuantiFERON® assay in young children investigated for tuberculosis in South Africa
S. Moyo et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
Carlos G. Grijalva et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials
Erica D. Dommasch et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients
A. I. Sanchez-Moya et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Economic burden of comorbidities in patients with psoriasis is substantial
A. B. Kimball et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Psoriasis and Obesity: A Review and Practical Recommendations
M. M. Farias et al.
ACTAS DERMO-SIFILIOGRAFICAS (2011)
Th1 and Th17 cells Adversaries and collaborators
Jesse M. Damsker et al.
YEAR IN IMMUNOLOGY 2 (2010)
Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area
Leia C. R. Silva et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2010)
Evidence-Based Comparison of Commercial Interferon-γ Release Assays for Detecting Active TB
Roland Diel et al.
CHEST (2010)
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
I. Solovic et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
Shinji Kagami et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
Batya B. Davidovici et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
Anne-Marie Tobin et al.
JOURNAL OF RHEUMATOLOGY (2010)
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies
S. Prey et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Incidence of psoriasis and association with comorbidities in Italy: A 5-year observational study from a national primary care database
Gino A. Vena et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2010)
Adverse reactions during biological therapy for psoriasis: Results of a survey of the Spanish Psoriasis Group
M. Sanchez-Regana et al.
ACTAS DERMO-SIFILIOGRAFICAS (2010)
Comorbidities in Patients with Psoriasis
Alice B. Gottlieb et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Risk of Tuberculosis Is Higher With Anti-Tumor Necrosis Factor Monoclonal Antibody Therapy Than With Soluble Tumor Necrosis Factor Receptor Therapy The Three-Year Prospective French Research Axed on Tolerance of Biotherapies Registry
F. Tubach et al.
ARTHRITIS AND RHEUMATISM (2009)
Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin test
E. Laffitte et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Economic burden of psoriasis compared to the general population and stratified by disease severity
Andrew P. Yu et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Tuberculin Skin Test Overestimates Tuberculosis Hypersensitivity in Adult Patients with Psoriasis
G. Tsiouri et al.
DERMATOLOGY (2009)
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases
F. Bartalesi et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
IFN-gamma release assays in tuberculosis management in selected high-risk populations
Marialuisa Bocchino et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Yeonseok Chung et al.
IMMUNITY (2009)
Treatments for psoriasis and the risk of malignancy
Rita V. Patel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Within-Subject Variability of Interferon-g Assay Results for Tuberculosis and Boosting Effect of Tuberculin Skin Testing: A Systematic Review
Richard N. van Zyl-Smit et al.
PLOS ONE (2009)
Differential Diagnosis of Psoriasis
Nicola Balato et al.
JOURNAL OF RHEUMATOLOGY (2009)
Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay
G. Matulis et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy
Der-Yuan Chen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Screening for tuberculosis infection prior to initiation of anti-TNF therapy
Ajit Lalvani et al.
AUTOIMMUNITY REVIEWS (2008)
Comparison of tuberculin skin test and interferon-gamma assays in patients with moderate to severe psoriasis who are candidates for antitumour necrosis factor-alpha therapy
N. Balato et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Indeterminate results on the interferon-gamma release assay for tuberculosis screening should not be ignored
H. H. Oon et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Association of infections and tuberculosis with antitumor necrosis factor alpha therapy
Nivedita M. Patkar et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Performance of two commercial blood IFN-γ release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-α treatment
M. Bocchino et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents
Sean D. Doherty et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening
Alexa B. Kimball et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Regional distribution of psoriasis in Italy
R. Saraceno et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
The clinical spectrum of psoriasis
Luigi Naldi et al.
CLINICS IN DERMATOLOGY (2007)
Development of systemic lupus erythematosus with focal proliferative lupus nephritis during Anti-TNF-α therapy for psoriatic arthritis
Hendrik Haake et al.
MEDIZINISCHE KLINIK (2007)
Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists
Haifa Hamdi et al.
ARTHRITIS RESEARCH & THERAPY (2006)
BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment
LP Ormerod et al.
THORAX (2005)
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
L Carmona et al.
ARTHRITIS AND RHEUMATISM (2005)
Psoriasis: dysregulation of innate immunity
JD Bos et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction
RS Stern et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2004)
Erythroderma: 90% skin failure
P Balasubramaniam et al.
HOSPITAL MEDICINE (2004)
Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration
SL Brown et al.
ARTHRITIS AND RHEUMATISM (2002)
Psoriasis - epidemiology and clinical spectrum
E Christophers
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2001)
Diagnostic standards and classification of tuberculosis in adults and children
NE Dunlap et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
